Similar Articles
891 Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects
892 Progress in systemic therapy of advanced hepatocellular carcinoma
893 Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria
894 Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma
895 Correlation of magnetic resonance signal characteristics and perfusion parameters assessed by volume perfusion computed tomography in hepatocellular carcinoma: Impact on lesion characterization
896 Specific CD8+ T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis
897 Diabetes mellitus and metformin in hepatocellular carcinoma
898 Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?
899 Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma
900 Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA